Leen A. F. M. van Garsse

Learn More
BACKGROUND Transcatheter aortic valve implantation (TAVI) is a novel therapy for treatment of severe aortic stenosis. Although 30% to 50% of patients develop new left bundle-branch block (LBBB), its effect on clinical outcome is unclear. METHODS AND RESULTS Data were collected in a multicenter registry encompassing TAVI patients from 2005 until 2010. The(More)
PURPOSE To assess current antithrombotic treatment strategies in the Netherlands in patients undergoing transcatheter aortic valve implantation (TAVI). METHODS For every Dutch hospital performing TAVI (n = 14) an interventional cardiologist experienced in performing TAVI was interviewed concerning heparin, aspirin, thienopyridine and oral anticoagulation(More)
In the recent years minimally invasive mitral valve surgery (MIMVS) has become a well-established and increasingly used option for managing patients with a mitral valve pathology. Nonetheless, whether the purported benefits of MIMVS translate into clinically important outcomes remains controversial. Therefore, in this paper we provide an overview of MIMVS(More)
OBJECTIVES To determine the optimal imaging time point for transcatheter aortic valve implantation (TAVI) therapy planning by comprehensive evaluation of the aortic root. METHODS Multidetector-row CT (MDCT) examination with retrospective ECG gating was retrospectively performed in 64 consecutive patients referred for pre-TAVI assessment. Eighteen(More)
T ranscatheter valve-in-valve implantation is a promising treatment option for degenerated bioprosthetic heart valves in high-risk patients. 1 Successful percutaneous techniques have been described for pulmonary and aortic valves. 2,3 We present the first successful percutaneous tricus-pid valve-in-valve implantation. The patient was a fragile 74-year-old(More)
Dear Editor, After traumatic freshwater submer-sion, severe respiratory failure and destructive lung injury are dreaded complications [1]. If conventional treatment fails to provide adequate oxygenation, veno-venous extracor-poreal membrane oxygenation (VV-ECMO) is the only remaining treatment modality [2]. Yet, in the presence of concomitant trauma, the(More)
The "hybrid" approach to multivessel coronary artery disease combines surgical left internal thoracic artery (LITA) to left anterior descending coronary artery (LAD) bypass grafting and percutaneous coronary intervention of the remaining lesions. Ideally, the LITA to LAD bypass graft is performed in a minimally invasive fashion. This review aims to clarify(More)
AIMS We retrospectively evaluated left atrial (LA) strain and strain rate (SR) before and after undersized mitral ring annuloplasty (UMRA) for chronic ischaemic mitral regurgitation (CIMR) with two-dimensional speckle-tracking echocardiography. METHODS AND RESULTS Left atrial volumes, LA reservoir, LA conduit, LA contractile phases, and LA ejection(More)
  • 1